欧洲防晒剂与非甾体抗炎药光过敏的前瞻性多中心光斑贴试验研究
该前瞻性多中心研究在7个欧洲国家的10个中心对防晒剂、NSAIDs等进行了光斑贴试验,并比较了照射前24小时与48小时封包的影响。结果显示10%(13/132)的参与者对防晒剂化学成分反应,9%(9/101)对NSAIDs反应;24小时封包相比48小时封包漏诊了53%的防晒剂光过敏反应和36%的NSAID反应。建议如可行采用48小时封包以提高光过敏检出率。
要点
- 防晒剂化学成分光过敏反应率为10%(13/132),NSAIDs为9%(9/101)。
- 最常见的光过敏原为酮洛芬(n=6)、异丙嗪(n=4)、阿伏苯宗(n=4)等。
- 24小时封包相比48小时封包漏诊53%防晒剂和36%NSAID光过敏反应,建议48小时封包。
核心结论
- 光斑贴试验仍是疑似光接触过敏者的重要检查手段,局部光过敏原性质似稳定但需持续监测。
- 为提高光过敏检出率,建议如可行采用照射前48小时封包。
研究设计与样本
- 前瞻性多中心研究,在7个欧洲国家的10个中心对防晒剂、NSAIDs及其他药物进行光斑贴试验。
- 研究设计包含自身对照比较照射前24小时与48小时封包对光斑贴试验结果的影响。
主要发现
- 共观察到28例光过敏反应,10%(13/132)的参与者对防晒剂化学成分反应,9%(9/101)对NSAIDs反应。
- 最常见的光过敏原为酮洛芬(n=6)、异丙嗪(n=4)、阿伏苯宗(n=4)、二苯酮-3(n=3)和依托芬那酯(n=3)。
- 接触过敏反应较少见(14例反应)。
- 24小时封包相比48小时封包,漏诊53%的防晒剂光过敏反应和36%的NSAID反应。
- 49%的参与者有皮肤病病史,大多数有光暴露部位皮炎或防晒剂/NSAID反应史或光敏感疾病。
关键数值与推荐
- 防晒剂化学成分光过敏反应率10%(13/132),NSAIDs光过敏反应率9%(9/101)。
- 24小时封包漏诊率:防晒剂53%,NSAIDs 36%(与48小时封包相比)。
临床怎么用
- 对疑似光接触过敏者应进行光斑贴试验,并尽可能采用照射前48小时封包以提高检出率。
- 所有光斑贴试验阳性者中涵盖了各种测试指征,无特定高危指征可预测光过敏。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Whilst photopatch testing is recognized as the investigation of choice for photoallergic contact dermatitis, changes in potential photoallergen exposure and variables within the photopatch test technique, have led to challenges in its usage within dermatology. OBJECTIVES: The main objectives of this study were to determine the nature and prevalence of topical photoallergens in Europe and investigate the variable of photoallergen occlusion time before irradiation, on photopatch testing outcomes. METHODS: A prospective multi-centre study of photopatch testing to sunscreens, non-steroidal anti-inflammatory drugs (NSAIDs) and other agents was conducted in 10 centres across seven European countries. A within-subject comparison of a 24h and 48h occlusion period prior to irradiation was included in the study design, to investigate the effect of this variable on photopatch testing outcomes. RESULTS: Of study participants, 28 photoallergic reactions were seen, with 10% (13/132) of participants reacting to sunscreen chemicals and 9% (9/101) to NSAIDs. The most prevalent photoallergens were ketoprofen (n=6), promethazine (n=4); butylmethoxydibenzoylmethane (Avobenzone/Parsol 1789) (n=4), benzophenone-3 (oxybenzone) (n=3) and etofenamate (n=3). Contact allergies were less frequent (14 reactions). When a 24h occlusion was used prior to irradiation, 53% of sunscreen photoallergic reactions and 36% of NSAID reactions were missed compared with the 48h occlusion. Most participants had a history of photo-exposed site dermatitis or sunscreen/NSAID reaction or had a photosensitivity disease, and 49% of participants had a history of dermatological conditions. All indications for photopatch testing were represented in those with positive photopatch tests, with no specific indicator of those most at risk. CONCLUSIONS: Photopatch testing remains an essential investigation for people with suspected photocontact allergies. Based on these study findings, the nature of topical photoallergens appears stable, but vigilance and ongoing review are required. To optimise the pick-up rate of photoallergy, we recommend, if practicable, a 48h occlusion period prior to irradiation.(Clinicaltrials.gov - NCT03812887).
引用
- Ralph N, Goossens A, Carrascosa JM, et al. Prospective Multi-Centre Photopatch Test Study of Photoallergy to Sunscreens and NSAIDs in Europe. Br J Dermatol. 2026. PMID: 41903515. doi:10.1093/bjd/ljag085
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。